1. Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing
   Agnieszka Śmieszek et al, 2024, BMC Cancer CrossRef
2. Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis
   Ichiro Murakami et al, 2015, Cell Communication and Signaling CrossRef
3. Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity
   Jenée Mitchell et al, 2020, Clinical Immunology CrossRef
4. Human skin explants an in vitro approach for assessing UVB induced damage
   Christian Khalil, 2018, Toxicology in Vitro CrossRef
5. Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis
   Yusuke Takei et al, 2017, Oncotarget CrossRef
6. Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis
   Yuka Nabeshima et al, 2021, Pathology International CrossRef